{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:45:48Z","timestamp":1793144748393,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005278","name":"Universidad de Antioquia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["111584467553"],"award-info":[{"award-number":["111584467553"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["111571249724"],"award-info":[{"award-number":["111571249724"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["111577757051"],"award-info":[{"award-number":["111577757051"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020075","name":"Corporaci\u00f3n Universitaria Remington","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020075","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Although combined antiretroviral therapy (cART) has decreased the mortality associated with HIV infection, complete immune reconstitution is not achieved despite viral suppression. Alterations of CD8<jats:sup>+<\/jats:sup>T cells and some of their subpopulations, such as interleukin (IL)-17-producing cells, are evidenced in treated individuals and are associated with systemic inflammation and adverse disease outcomes. We sought to evaluate if different CD8<jats:sup>+<\/jats:sup>T cell subsets are differentially normalized during a clinical follow-up of people living with HIV (PLWH) receiving suppressive cART.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We explored the changes in the frequencies, activation\/exhaustion phenotypes (HLA-DR, CD38, PD-1, and TIM-3), and function (total and HIV-specific cells expressing CD107a, perforin, granzyme B, interferon [IFN]-\u03b3 and IL-17) of CD8<jats:sup>+<\/jats:sup>T cells from early-treated PLWH receiving cART in a 1-year follow-up, using a multidimensional flow cytometry approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Despite continuous cART-induced viral suppression and recovery of CD4<jats:sup>+<\/jats:sup>T cells, after a 1-year follow-up, the CD8<jats:sup>+<\/jats:sup>T cell counts, CD4:CD8 ratio, PD-1 expression, and IL-17 production by CD8<jats:sup>+<\/jats:sup>T cells exhibited incomplete normalization compared with seronegative controls. However, the proportion of CD8<jats:sup>+<\/jats:sup>T cells with an exhausted phenotype (co-expressing PD-1 andTIM-3), and cells co-expressing cytotoxic molecules (Perforin and Granzyme B), reached normalization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although suppressive cART achieves normalization of CD4<jats:sup>+<\/jats:sup>T cell counts, only particular subsets of CD8<jats:sup>+<\/jats:sup>T cells are more rapidly normalized in PLWH receiving cART, which could be routinely used as biomarkers for therapy efficiency in these patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12981-022-00465-0","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T13:07:40Z","timestamp":1663160860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of CD8+ T cell subsets that normalize in early-treated people living with HIV receiving antiretroviral therapy"],"prefix":"10.1186","volume":"19","author":[{"given":"Federico","family":"Perdomo-Celis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Arcia-Anaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Alzate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Velilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paulina","family":"Posada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda T.","family":"Rugeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia A.","family":"Taborda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"issue":"1","key":"465_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14787210.2017.1250624","volume":"15","author":"A Bandera","year":"2017","unstructured":"Bandera A, Colella E, Rizzardini G, Gori A, Clerici M. Strategies to limit immune-activation in HIV patients. Expert Rev Anti Infect Ther. 2017;15(1):43\u201354.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"465_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/JLB.4MR1019-189R","volume":"107","author":"X Yang","year":"2020","unstructured":"Yang X, Su B, Zhang X, Liu Y, Wu H, Zhang T. Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: challenges of immunological non-responders. J Leukoc Biol. 2020;107(4):597\u2013612.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"465_CR3","doi-asserted-by":"publisher","first-page":"e1005661","DOI":"10.1371\/journal.ppat.1005661","volume":"12","author":"M Hoffmann","year":"2016","unstructured":"Hoffmann M, Pantazis N, Martin GE, Hickling S, Hurst J, Meyerowitz J, et al. Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection. PLoS Pathog. 2016;12(7):e1005661.","journal-title":"PLoS Pathog"},{"issue":"3","key":"465_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/v14030581","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun Y, Xue J. Expression profile and biological role of immune checkpoints in disease progression of HIV\/SIV infection. Viruses. 2022;14(3):581.","journal-title":"Viruses"},{"key":"465_CR5","doi-asserted-by":"publisher","first-page":"104090","DOI":"10.1016\/j.ebiom.2022.104090","volume":"81","author":"M Calvet-Mirabent","year":"2022","unstructured":"Calvet-Mirabent M, Sanchez-Cerrillo I, Martin-Cofreces N, Martinez-Fleta P, de la Fuente H, Tsukalov I, et al. Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV. EBioMedicine. 2022;81:104090.","journal-title":"EBioMedicine"},{"issue":"4","key":"465_CR6","doi-asserted-by":"publisher","first-page":"e004564","DOI":"10.1136\/jitc-2022-004564","volume":"10","author":"O Chaudhary","year":"2022","unstructured":"Chaudhary O, Trotta D, Wang K, Wang X, Chu X, Bradley C, et al. Patients with HIV-associated cancers have evidence of increased T cell dysfunction and exhaustion prior to cancer diagnosis. J Immunother Cancer. 2022;10(4):e004564.","journal-title":"J Immunother Cancer"},{"key":"465_CR7","doi-asserted-by":"publisher","first-page":"875692","DOI":"10.3389\/fimmu.2022.875692","volume":"13","author":"S Dominguez-Rodriguez","year":"2022","unstructured":"Dominguez-Rodriguez S, Tagarro A, Foster C, Palma P, Cotugno N, Zicari S, et al. Clinical, virological and immunological subphenotypes in a cohort of early treated HIV-infected children. Front Immunol. 2022;13:875692.","journal-title":"Front Immunol"},{"issue":"7109","key":"465_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443(7109):350\u20134.","journal-title":"Nature"},{"issue":"1","key":"465_CR9","doi-asserted-by":"publisher","first-page":"e0210540","DOI":"10.1371\/journal.pone.0210540","volume":"14","author":"F Perdomo-Celis","year":"2019","unstructured":"Perdomo-Celis F, Velilla PA, Taborda NA, Rugeles MT. An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression. PLoS ONE. 2019;14(1):e0210540.","journal-title":"PLoS ONE"},{"key":"465_CR10","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3389\/fimmu.2018.02502","volume":"9","author":"F Perdomo-Celis","year":"2018","unstructured":"Perdomo-Celis F, Feria MG, Taborda NA, Rugeles MT. A low frequency of IL-17-producing CD8(+) T-cells is associated with persistent immune activation in people living with HIV despite HAART-induced viral suppression. Front Immunol. 2018;9:2502.","journal-title":"Front Immunol"},{"issue":"22","key":"465_CR11","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1128\/JVI.01153-09","volume":"83","author":"SA Migueles","year":"2009","unstructured":"Migueles SA, Weeks KA, Nou E, Berkley AM, Rood JE, Osborne CM, et al. Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol. 2009;83(22):11876\u201389.","journal-title":"J Virol"},{"key":"465_CR12","doi-asserted-by":"crossref","first-page":"395484","DOI":"10.1155\/2015\/395484","volume":"2015","author":"G d'Ettorre","year":"2015","unstructured":"d\u2019Ettorre G, Ceccarelli G, Andreotti M, Selvaggi C, Giustini N, Serafino S, et al. Analysis of Th17 and Tc17 frequencies and antiviral defenses in gut-associated lymphoid tissue of chronic HIV-1 positive patients. Mediat Inflamm. 2015;2015:395484.","journal-title":"Mediat Inflamm"},{"issue":"11","key":"465_CR13","doi-asserted-by":"publisher","first-page":"e3572","DOI":"10.1093\/cid\/ciaa1391","volume":"73","author":"MA Thompson","year":"2021","unstructured":"Thompson MA, Horberg MA, Agwu AL, Colasanti JA, Jain MK, Short WR, et al. Primary Care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2021;73(11):e3572\u2013605.","journal-title":"Clin Infect Dis"},{"issue":"26","key":"465_CR14","doi-asserted-by":"publisher","first-page":"E2770","DOI":"10.1073\/pnas.1408792111","volume":"111","author":"RV Bruggner","year":"2014","unstructured":"Bruggner RV, Bodenmiller B, Dill DL, Tibshirani RJ, Nolan GP. Automated identification of stratifying signatures in cellular subpopulations. Proc Natl Acad Sci USA. 2014;111(26):E2770\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"RR-03","key":"465_CR15","first-page":"1","volume":"63","author":"Centers for Disease C, Prevention","year":"2014","unstructured":"Centers for Disease C, Prevention. Revised surveillance case definition for HIV infection\u2014United States, 2014. MMWR Recomm Rep. 2014;63(RR-03):1\u201310.","journal-title":"MMWR Recomm Rep"},{"key":"465_CR16","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3389\/fimmu.2020.01350","volume":"11","author":"S Vigano","year":"2020","unstructured":"Vigano S, Bobisse S, Coukos G, Perreau M, Harari A. Cancer and HIV-1 infection: patterns of chronic antigen exposure. Front Immunol. 2020;11:1350.","journal-title":"Front Immunol"},{"issue":"4","key":"465_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/QAI.0000000000000500","volume":"68","author":"FH Cortes","year":"2015","unstructured":"Cortes FH, Passaes CP, Bello G, Teixeira SL, Vorsatz C, Babic D, et al. HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles. J Acquir Immune Defic Syndr. 2015;68(4):377\u201385.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"465_CR18","doi-asserted-by":"publisher","first-page":"e1004078","DOI":"10.1371\/journal.ppat.1004078","volume":"10","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, et al. HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014;10(5):e1004078.","journal-title":"PLoS Pathog"},{"issue":"2","key":"465_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/infdis\/jiw146","volume":"214","author":"V Cobos Jimenez","year":"2016","unstructured":"Cobos Jimenez V, Wit FW, Joerink M, Maurer I, Harskamp AM, Schouten J, et al. T-cell activation independently associates with immune senescence in HIV-infected recipients of long-term antiretroviral treatment. J Infect Dis. 2016;214(2):216\u201325.","journal-title":"J Infect Dis"},{"issue":"10","key":"465_CR20","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1097\/QAD.0000000000002248","volume":"33","author":"N Pantazis","year":"2019","unstructured":"Pantazis N, Papastamopoulos V, Paparizos V, Metallidis S, Adamis G, Antoniadou A, et al. Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy. AIDS. 2019;33(10):1645\u201355.","journal-title":"AIDS"},{"issue":"8","key":"465_CR21","doi-asserted-by":"publisher","first-page":"e0219201","DOI":"10.1371\/journal.pone.0219201","volume":"14","author":"R Greenblatt","year":"2019","unstructured":"Greenblatt R, Bacchetti P, Boylan R, Kober K, Springer G, Anastos K, et al. Genetic and clinical predictors of CD4 lymphocyte recovery during suppressive antiretroviral therapy: whole exome sequencing and antiretroviral therapy response phenotypes. PLoS ONE. 2019;14(8):e0219201.","journal-title":"PLoS ONE"},{"issue":"3","key":"465_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/hiv.12567","volume":"19","author":"OT Stirrup","year":"2018","unstructured":"Stirrup OT, Copas AJ, Phillips AN, Gill MJ, Geskus RB, Touloumi G, et al. Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion. HIV Med. 2018;19(3):184\u201394.","journal-title":"HIV Med"},{"issue":"4","key":"465_CR23","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.4049\/jimmunol.1302027","volume":"192","author":"S Bastidas","year":"2014","unstructured":"Bastidas S, Graw F, Smith MZ, Kuster H, Gunthard HF, Oxenius A. CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals. J Immunol. 2014;192(4):1732\u201344.","journal-title":"J Immunol"},{"key":"465_CR24","doi-asserted-by":"publisher","first-page":"20052","DOI":"10.7448\/IAS.18.1.20052","volume":"18","author":"W Lu","year":"2015","unstructured":"Lu W, Mehraj V, Vyboh K, Cao W, Li T, Routy JP. CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients. J Int AIDS Soc. 2015;18:20052.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"465_CR25","doi-asserted-by":"publisher","first-page":"e1005805","DOI":"10.1371\/journal.ppat.1005805","volume":"12","author":"KR Demers","year":"2016","unstructured":"Demers KR, Makedonas G, Buggert M, Eller MA, Ratcliffe SJ, Goonetilleke N, et al. Temporal dynamics of CD8+ T cell effector responses during primary HIV infection. PLoS Pathog. 2016;12(8):e1005805.","journal-title":"PLoS Pathog"},{"issue":"1","key":"465_CR26","doi-asserted-by":"publisher","first-page":"20697","DOI":"10.7448\/IAS.19.1.20697","volume":"19","author":"W Cao","year":"2016","unstructured":"Cao W, Mehraj V, Kaufmann DE, Li T, Routy JP. Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era. J Int AIDS Soc. 2016;19(1):20697.","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"465_CR27","doi-asserted-by":"publisher","first-page":"e109791","DOI":"10.1371\/journal.pone.0109791","volume":"9","author":"G d'Ettorre","year":"2014","unstructured":"d\u2019Ettorre G, Baroncelli S, Micci L, Ceccarelli G, Andreotti M, Sharma P, et al. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial. PLoS ONE. 2014;9(10):e109791.","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"465_CR28","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1097\/QAI.0000000000002838","volume":"89","author":"JP Routy","year":"2022","unstructured":"Routy JP, Royston L, Isnard S. Aging with grace for people living with HIV: strategies to overcome leaky gut and cytomegalovirus coinfection. J Acquir Immune Defic Syndr. 2022;89(Suppl 1):S29\u201333.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"465_CR29","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI85996","volume":"126","author":"SA Younes","year":"2016","unstructured":"Younes SA, Freeman ML, Mudd JC, Shive CL, Reynaldi A, Panigrahi S, et al. IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection. J Clin Invest. 2016;126(7):2745\u201356.","journal-title":"J Clin Invest"},{"issue":"11","key":"465_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/2047-783X-16-11-473","volume":"16","author":"C Shou","year":"2011","unstructured":"Shou C, Weng N, Jin Y, Feng L, Jin C, Hoextermann S, et al. Study of T cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART. Eur J Med Res. 2011;16(11):473\u20139.","journal-title":"Eur J Med Res"},{"key":"465_CR31","first-page":"7316456","volume":"2021","author":"T Lv","year":"2021","unstructured":"Lv T, Cao W, Li T. HIV-related immune activation and inflammation: current understanding and strategies. J Immunol Res. 2021;2021:7316456.","journal-title":"J Immunol Res"},{"issue":"8","key":"465_CR32","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/infdis\/jiu254","volume":"210","author":"AR Tenorio","year":"2014","unstructured":"Tenorio AR, Zheng Y, Bosch RJ, Krishnan S, Rodriguez B, Hunt PW, et al. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis. 2014;210(8):1248\u201359.","journal-title":"J Infect Dis"},{"issue":"5","key":"465_CR33","doi-asserted-by":"publisher","first-page":"e0155100","DOI":"10.1371\/journal.pone.0155100","volume":"11","author":"B Grund","year":"2016","unstructured":"Grund B, Baker JV, Deeks SG, Wolfson J, Wentworth D, Cozzi-Lepri A, et al. Relevance of Interleukin-6 and D-dimer for serious non-AIDS morbidity and death among HIV-positive adults on suppressive antiretroviral therapy. PLoS ONE. 2016;11(5):e0155100.","journal-title":"PLoS ONE"},{"key":"465_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.meegid.2017.11.002","volume":"57","author":"JM Valverde-Villegas","year":"2018","unstructured":"Valverde-Villegas JM, de Medeiros RM, Ellwanger JH, Santos BR, Melo MG, Almeida SEM, et al. High CXCL10\/IP-10 levels are a hallmark in the clinical evolution of the HIV infection. Infect Genet Evol. 2018;57:51\u20138.","journal-title":"Infect Genet Evol"},{"issue":"4","key":"465_CR35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/QAD.0b013e32835b8cb3","volume":"27","author":"JC Gaardbo","year":"2013","unstructured":"Gaardbo JC, Hartling HJ, Thorsteinsson K, Ullum H, Nielsen SD. CD3+CD8+CD161high Tc17 cells are depleted in HIV-infection. AIDS. 2013;27(4):659\u201362.","journal-title":"AIDS"},{"issue":"12","key":"465_CR36","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1128\/JVI.00600-13","volume":"87","author":"SL Bixler","year":"2013","unstructured":"Bixler SL, Sandler NG, Douek DC, Mattapallil JJ. Suppressed Th17 levels correlate with elevated PIAS3, SHP2, and SOCS3 expression in CD4 T cells during acute simian immunodeficiency virus infection. J Virol. 2013;87(12):7093\u2013101.","journal-title":"J Virol"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-022-00465-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-022-00465-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-022-00465-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T21:26:47Z","timestamp":1727990807000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-022-00465-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["465"],"URL":"https:\/\/doi.org\/10.1186\/s12981-022-00465-0","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Universidad de Antioquia (certificates 15-08-634 and 11-08-352). All experiments followed the principles expressed in the Declaration of Helsinki. Written participation consent was obtained from each participant. No minors were included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}